SUCCESSFUL TREATMENT OF CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION WITH RECOMBINANT INTERLEUKIN-2
- 1 January 1987
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 329 (8525) , 154
- https://doi.org/10.1016/s0140-6736(87)91980-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- Chronic, symptomatic Epstein-Barr virus infectionsImmunology Today, 1986
- Antibody Responses to Two Epstein-Barr Virus Nuclear Antigens Defined by Gene TransferNew England Journal of Medicine, 1985
- Evidence for Active Epstein-Barr Virus Infection in Patients with Persistent, Unexplained Illnesses: Elevated Anti-Early Antigen AntibodiesAnnals of Internal Medicine, 1985
- Cell‐mediated immunity to Epstein‐Barr virus (EBV) and natural killer (NK)‐cell activity in the X‐linked lymphoproliferative syndromeInternational Journal of Cancer, 1982
- Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitroEuropean Journal of Immunology, 1981
- Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative SyndromeScience, 1980